CAVAMAX® W8 PHARMA
CAVAMAX® W8 PHARMA is pharmaceutical grade gamma-cyclodextrin from Wacker Chemie AG. CAVAMAX® W8 PHARMA with 8 glucose units has the largest cavity of the parent cyclodextrins and is the most water soluble. It is useful for solubilizing, stabilizing or delivering larger molecules macrocyclics, oils, lipids, etc.
- INCI: Cyclodextrin
- DMF Type IV, No 11375
- White powder
- Pharmaceutical grade: Content min. 98.0%, complies with current USP/NF monographs specifications
- REACH: full registration
- Sole manufacturer globally
All the information provided is in accordance with the present state of our knowledge. Nonetheless, we disclaim any warranty or liability whatsoever and reserve the right, at any time, to effect technical alterations. The information provided, as well as the product's fitness for an intended application, should be checked by the buyer in preliminary trials. Contractual terms and conditions always take precedence. This disclaimer of warranty and liability also applies particularly in foreign countries with respect to third parties' rights.
- Solubilization, stabilization and delivery of large active ingredients, e.g. steroids, lipids
- Enhancement of both oral bioavailability and taste masking of pharmaceutical active ingredients; enabling of delayed release
Storage at room temperature in sealed containers under dry conditions is recommended. CAVAMAX® W8 Pharma has a shelf live of at least 36 months when stored in unbroken original packaging in dry storage areas. The best use before date of each batch is shown on the product label. Storage beyond the date specified on the label does not necessarily mean that the product is no longer usable. In this case however, the properties required for the intended use must be checked for quality assurance reasons.
WACKER has a global network of specialist distributors at its disposal. Please select an application so that we can suggest suitable contacts.